AGIOS PHARMACEUTICALS, INC.
Patent Owner
Stats
- 36 US PATENTS IN FORCE
- 6 US APPLICATIONS PENDING
- Mar 08, 2018 most recent publication
Details
- 36 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,447 Total Citation Count
- Mar 12, 2010 Earliest Filing
- 16 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0325,708 METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERSMay 08, 17Nov 16, 17[A61K, C12Q, C12N, G01N, A61B, G06F]
2017/0015,703 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USESep 28, 16Jan 19, 17[A61K, C07K]
2017/0007,661 PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDSMar 13, 15Jan 12, 17[A61K, G01N]
2016/0304,556 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USEJun 29, 16Oct 20, 16[A61K, C07K]
2016/0229,876 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USEApr 15, 16Aug 11, 16[A61K, C07F, C07D]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9856279 Therapeutically active compositions and their methods of useApr 15, 16Jan 02, 18[A61K, C07F, C07D]
9850277 Therapeutically active compositions and their methods of useSep 28, 16Dec 26, 17[A61K, C07D, C07K]
9738625 Therapeutically active compounds and their methods of useAug 01, 14Aug 22, 17[A61K, C07D, A61P]
9724350 N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancerJul 10, 14Aug 08, 17[A61K, C07D, A61P]
9662327 Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancerJun 18, 12May 30, 17[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0280,697 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USEAbandonedMar 24, 16Sep 29, 16[C07D]
2016/0264,621 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USEAbandonedMar 09, 16Sep 15, 16[C07D, C07C, C07K]
2015/0240,286 METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERSAbandonedOct 02, 14Aug 27, 15[C12Q]
2015/0087,600 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USEAbandonedJan 21, 13Mar 26, 15[A61K, C07K]
2015/0031,627 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USEAbandonedJul 25, 14Jan 29, 15[A61K, C07K]
2014/0323,729 PYRUVATE KINASE M2 MODULATORS, THERAPEUTIC COMPOSITIONS AND RELATED METHODS OF USEAbandonedMay 15, 14Oct 30, 14[C07D]
2014/0249,150 ACTIVATORS OF PYRUVATE KINASE M2 AND METHODS OF TREATING DISEASEAbandonedOct 12, 12Sep 04, 14[A61K, C07D]
2014/0213,580 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USEAbandonedJun 18, 12Jul 31, 14[A61K, C07D]
2014/0187,435 METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERSAbandonedJul 11, 13Jul 03, 14[C12Q, A61B, G06F]
2013/0184,222 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USEAbandonedJul 15, 11Jul 18, 13[C07D, C07C, C07K]
2013/0035,329 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USEAbandonedJun 08, 12Feb 07, 13[A61K, C07D, A61P]
2012/0121,515 METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERSAbandonedMar 12, 10May 17, 12[A61K, C12Q, G01N]
2012/0041,070 METHODS OF TREATING CANCER HAVING AN ABERRANT EGFR OR KRAS GENOTYPEAbandonedSep 30, 11Feb 16, 12[A61K, C12N, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.